We also demonstrated that inhibition of the activity of either MMP‐9 or TGF‐β sufficiently blocked the MMP‐9 overexpression induced the activation of SMAD signalling and enhancement on invasion in the breast cancer cell lines. The gene discussed is MMP9; the disease is breast carcinoma.